Request Appointment
12902 Magnolia Dr.Tampa, FL 33612
Fax+1 813-745-3875
Overview of Dr. Saeed
An associate member at Moffitt cancer center specializing in the treatment of Hodgkins, T cell and B cell lymphoma.
Education & Training
University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 2013 - 2016- University of Kentucky College of MedicineResidency, Internal Medicine, 2010 - 2013
University of Baghdad College of MedicineClass of 2006
Certifications & Licensure
FL State Medical License 2019 - 2027
KY State Medical License 2013 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- AACR/ASCO Clinical trial workshop in Vail,CO AACR/ASCO, 2016
- Letter of Achievement UK hematology oncology fellowship program, 2015-2016
- Clinical trial boot camp Markey Cancer Center, 2014
- Join now to see all
Clinical Trials
- Pentamidine + Salvage Chemo for Relapsed/Refractory Classical Hodgkin Lymphoma Start of enrollment: 2018 Dec 19
Publications & Presentations
PubMed
- Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic c...Timothy J Voorhees, Eric M McLaughlin, Pallawi Torka, Jorge Florindez, Na Hyun Kim
Blood Cancer Journal. 2025-03-26 - Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Confere...Alexey V Danilov, Craig Sauter, Tycel Phillips, Catherine C Coombs, Andrew Ip
Clinical Lymphoma, Myeloma & Leukemia. 2025-01-13 - 14 citationsNivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.Alex F Herrera, Michael LeBlanc, Sharon M Castellino, Hongli Li, Sarah C Rutherford
The New England Journal of Medicine. 2024-10-17
Journal Articles
- Age Adjusted Hematopoietic Stem Cell Transplant Comorbidity Index Predicts Survival in a T-cell Depleted Cohort☆Swati Yalamanchi, Hayder Saeed, Dianna Howard, Gerhard C Hildebrandt, Roger Herzig, Gregory Monohan, ScienceDirect
Abstracts/Posters
- Impact of Interim FDG-PET (iPET) in the Outcomes of Patients with Aggressive B-Cell Lymphomas Receiving DA-EPOCH-RHayder Saeed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Use of Lenalidomide Plus Rituximab in TP53-Mutated Mantle Cell Lymphoma (MCL) Outside of Clinic Trial: The Moffitt ExperienceHayder Saeed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Authored Content
- Unleashing the Spark: My Top #ASH23 Posts That Ignited EngagementDecember 2023
- Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?December 2022
- An Update on T Cell Lymphoma from SOHO 2021September 2021
Press Mentions
CME Information - May 2018January 28th, 2018
Professional Memberships
- Fellow
- Member
Other Languages
- Arabic
External Links
- Pubmed Profilehttp://goo.gl/3BmVhl
- Twitter https://twitter.com/HayderSaeed_MD
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
